The PurpleLab^® Resource Center

Higher SARS-COV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon from Roche Information Solutions, Roche Diagnostics GmbH, Roche Diagnostics Solutions, and Roche Diagnostics International presented a poster during ISPOR 2024. The objective was to assess the…

Performance DSP brings targeting, activation, optimization and measurement into one workflow for health and pharmaceutical advertisers.  Expanded integration with PurpleLab® adds real-world health intelligence that improves accuracy and verified outcome performance.  Nexxen, a global, flexible advertising platform with deep expertise in data and advanced TV, today announced the introduction of measurement and optimization into Nexxen…

This article was originally published at Healthcare Business Today.   The White House’s recent memorandum directing the FDA to rein in direct-to-consumer (DTC) pharmaceutical advertising has reignited a long-running debate about the role of advertising in American health.  Despite the back and forth, the administration’s critics and proponents should agree that misleading ads are not beneficial. However, removing…

Characterize the real-world CAR-T patient population by describing demographic and social drivers of health (SDOH) attributes at the time of therapy initiation.